Insider Transactions in Q2 2023 at Aclaris Therapeutics, Inc. (ACRS)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2023
|
Joseph Monahan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,000
-4.06%
|
$60,000
$10.28 P/Share
|
|
Jun 20
2023
|
Christopher P. Molineaux |
BUY
Exercise of conversion of derivative security
|
Direct |
16,500
+25.38%
|
$16,500
$1.41 P/Share
|
|
Jun 15
2023
|
Christopher P. Molineaux |
BUY
Exercise of conversion of derivative security
|
Direct |
249
+0.39%
|
$249
$1.12 P/Share
|
|
Jun 02
2023
|
William D. Humphries |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+15.77%
|
-
|
|
Jun 02
2023
|
Vincent Milano |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+36.43%
|
-
|
|
Jun 02
2023
|
Christopher P. Molineaux |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+12.43%
|
-
|
|
Jun 02
2023
|
Maxine Gowen |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+26.81%
|
-
|
|
Jun 02
2023
|
Bryan M. Reasons |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+15.77%
|
-
|
|
Jun 02
2023
|
Andrew Kenneth William Powell |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+23.88%
|
-
|
|
Jun 02
2023
|
Andrew N Schiff |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+50.0%
|
-
|
|
Jun 02
2023
|
Anand Mehra |
BUY
Exercise of conversion of derivative security
|
Direct |
4,507
+10.43%
|
-
|